MANAGEMENT OF STAGE-I MALIGNANT-MELANOMA

被引:13
|
作者
GREENSTEIN, DS
ROGERS, GS
机构
[1] BOSTON UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA 02118
[2] BOSTON UNIV,SCH MED,DEPT SURG,BOSTON,MA 02118
关键词
D O I
10.1111/j.1524-4725.1995.tb00528.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Because of the rising incidence of melanoma, dermatologists are increasingly responsible for diagnosing and managing patients with this cutaneous malignancy. Fortunately, with the increased awareness and emphasis on early detection, most patients will present with tumors that have not yet spread beyond their primary focus in the skin (ie, Stage I). Dermatologists must, therefore, be fully versed in the diagnosis and management of Stage I melanoma. OBJECTIVE. This review article focuses on the most important issues related to the diagnosis and management of Stage I mel anoma. An emphasis will be placed on surgical management. RESULTS. The mainstay of therapy for most patients with Stage I melanoma is surgery. The important principles of diagnostic biopsy and surgical excision will be discussed. There are several additional modalities that may be useful as adjuvants to surgical therapy or as primary therapy in situations when surgery is not feasible. Those include elective lymph node dissection, hyperthermic isolation limb perfusion, radiotherapy, cryotherapy, chemotherapy, and immunotherapy. These will all be reviewed. CONCLUSIONS. With a thorough understanding of the important principles and controversies related to the management of Stage I melanoma, dermatologists can effectively manage the growing number of patients with this malignancy.
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
  • [21] ADJUVANT BCG IMMUNOTHERAPY FOR STAGE-I AND STAGE-II MALIGNANT-MELANOMA
    SILVER, HKB
    IBRAHIM, EMA
    EVERS, JA
    THOMAS, JW
    MURRAY, RN
    SPINELLI, JJ
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 128 (11) : 1291 - 1295
  • [22] FOLLOW-UP RECOMMENDATIONS FOR PATIENTS WITH STAGE-I MALIGNANT-MELANOMA
    ROMERO, JB
    STEFANATO, CM
    KOPE, AW
    BART, RS
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1994, 20 (03): : 175 - 178
  • [23] THE IMPACT OF INTRADERMAL LYMPHOSCINTIGRAPHY ON SURGICAL-MANAGEMENT OF CLINICAL STAGE-I TRUNCAL MALIGNANT-MELANOMA
    KRAMER, EL
    SANGER, JJ
    GOLOMB, F
    KOPF, AW
    POSTEL, A
    [J]. JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1987, 13 (05): : 508 - 515
  • [24] MOHS MICROGRAPHIC SURGERY FOR THIN STAGE-I MALIGNANT-MELANOMA - RATIONALE FOR A MODERN MANAGEMENT STRATEGY
    KASPAR, TA
    WAGNER, RF
    [J]. CUTIS, 1992, 50 (05): : 350 - 351
  • [25] ADJUVANT CHEMO-IMMUNOTHERAPY STAGE-I STAGE-II MALIGNANT-MELANOMA
    KNOST, JA
    REYNOLDS, V
    GRECO, FA
    OLDHAM, RK
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1982, 19 (03) : 165 - 170
  • [26] VALUE OF PREOPERATIVE SCREENING PROCEDURES IN STAGE-I AND STAGE-II MALIGNANT-MELANOMA
    ARANHA, GV
    SIMMONS, RL
    GUNNARSSON, A
    GRAGE, TB
    MCKHANN, CF
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1979, 11 (01) : 1 - 6
  • [27] INEFFICACY OF ADJUVANT IMMUNOTHERAPY WITH C-PARVUM IN STAGE-I MALIGNANT-MELANOMA
    MURRAY, JL
    LEE, ET
    WEBER, K
    ISHMAEL, DR
    BOTTOMLEY, RH
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 526 - 526
  • [28] PREDICTIVE VALUE OF STAGING INVESTIGATIONS IN PATIENTS WITH CLINICAL STAGE-I MALIGNANT-MELANOMA
    ISCOE, N
    KERSEY, P
    GAPSKI, J
    OSOBA, D
    FROM, L
    DEBOER, G
    QUIRT, I
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1987, 80 (02) : 233 - 247
  • [29] CLINICAL STAGE-I MALIGNANT-MELANOMA OF THE SKIN - PROGNOSTIC FACTORS, SURVIVAL, AND TREATMENT
    LEDERMAN, JS
    SOBER, AJ
    DAY, CL
    FITZPATRICK, TB
    [J]. LYON MEDICAL, 1984, 252 (19-2): : 373 - 378
  • [30] ELECTIVE LYMPH-NODE DISSECTION IN STAGE-I MALIGNANT-MELANOMA - A METAANALYSIS
    HEIN, DW
    MOY, RL
    [J]. MELANOMA RESEARCH, 1992, 2 (04) : 273 - 277